Company News

Proteon-Award2-speech

Proteon Founder, Professor Jarosław Dastych, presents on “Aquaculture: Challenges and Lessons of Product Development” at the Bacteriophage Therapy Summit, Boston, USA.

Proteon Founder and Board Member, Professor Jarosław Dastych, made a major presentation at the Bacteriophage Therapy Summit in  Boston, USA. He spoke on the  topic  of ” Aquaculture: Challenges and Lessons of Product Development” The Bacteriophage Therapy Summit is the only meeting uniting large pharma, biotech companies, research institutions and technology experts to harness bacteriophage science and accelerate the clinical […]

Read More

Proteon-Award

Proteon receives the “Best Innovation in Aquaculture Award” at the Global Forum for Innovations in Agriculture (GFIA)

Proteon received the Best “Innovation in Aquaculture Award”, from His Excellency, Saeed Albahri Salem Alameri, and Hans van der Beek, Director General of the Abu Dhabi Agriculture and Food Safety Authority at the Global Forum for Innovations in Agriculture (GFIA) in Abu Dhabi. Tom Cook, VP. Global Business Development at Proteon Pharmaceuticals, accepted the award. The […]

Read More

Proteon Pharmaceuticals gives an extensive comment on Salmonella issue in Poland in a video interview for a Polish business wire agency

Cases of salmonellosis are a growing problem – their number has been steadily growing for the last two years exceeding the number of 10 thousand cases per year. One of the main sources of infection are eggs and poultry. Few months ago new set of rules was implemented regarding national program for the control of […]

Read More

Proteon Pharmaceuticals was invited to present its bacteriophage technology at the prestigious animal nutrition conference FIAAP in Bangkok

Proteon Pharmaceuticals was an invited speaker at the 9th edition of the FIAAP Animal Nutrition conference held on March 27, 2018 in Bangkok, Thailand. This one-day international conference highlighted the latest innovations and research in animal feed ingredients and additives. The event was co-located with five additional conferences as part of VICTAM Asia 2018. (more…)

Read More

Proteon Pharmaceuticals attracts environmental impact investment fund

October 24, 2017  – Proteon Pharmaceuticals S.A., a Polish biotechnology firm has signed an agreement with an international Investment Fund, the Aqua-Spark fund, which invests in sustainable aquaculture. Proteon Pharmaceuticals will use the funds to commercialize its products globally, develop production capacity and support the development of its bacteriophage-platform technology. Proteon Pharmaceuticals is a world […]

Read More

BAFADOR® presented at the international bacteriophage conference in Tbilisi

Proteon Pharmaceuticals presents its unique product BAFADOR® at the international bacteriophage conference in Tbilisi Proteon Pharmaceuticals participated in the international conference “Centennial Celebration of Bacteriophage Research”, held in Tbilisi, Georgia on June 26-29, 2017. Proteon Pharmaceuticals’ R&D Director, Dr Ewelina Wójcik, presented the results of Company’s research, which has led to development of a phage-based […]

Read More

Proteon Pharmaceuticals awarded grants for Euro 3.2 m

In 2016 Proteon Pharmaceuticals awarded grants from Polish Center for Research & Development for Euro 3.2 m In 2016, Proteon Pharmaceuticals signed the agreements for the co-financing five research projects from the European Union for Euro 3.2 million. The projects are for research and development of new generation, innovative products, based on our unique phage-platform […]

Read More